Xcout Intel
SonoThera
SonoThera, Inc. is a biotechnology company headquartered in South San Francisco, California, focused on developing genetic medicines and advancing the field of gene therapy.
Subscribe to see SonoThera’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
SonoThera at a glance
SonoThera is a biotech company headquartered in United States. Its most recent funding round, Series B, raised $125M in June 2026. Xcout tracks 12 named people at SonoThera, including Carolyne Zimmermann (Chief Business Officer). Xcout recorded 7 job postings from SonoThera in the last 90 days.
SonoThera leadership
- Carolyne ZimmermannChief Business Officer
- Kenneth Greenbergco-founder, and chief executive officer
- Michael Davidsonco-founder
- Steve Feinsteinco-founder
- Carolyne ZimmermanExecutive Officer
- Kenneth GreenbergExecutive Officer
6 more named people on record for SonoThera, with roles, board committees and tenure — see the full roster →
SonoThera funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series B | $125M | 13 named | |
| — | $60.8M | 14 named | |
| SEC Form D filing | $30.4M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Hiring at SonoThera
Xcout recorded 7 job postings from SonoThera in the last 90 days, from a hiring record Xcout has kept since June 2026.
The weekly hiring trend, the roles and locations behind it — see SonoThera's hiring signals →
Investors
Tech stack
SonoThera competitors
A few of SonoThera's closest competitors — see the full list of competitors and alternatives →
BreezeBio is a biotechnology company headquartered in the South San Francisco area of California that develops precision genetic medicines.
Encoded Therapeutics is a biotechnology company headquartered in South San Francisco, California, dedicated to developing next-generation genetic medicines designed to address the root causes of genetic diseases.
Neuron23 is a biotechnology company founded in 2018 that focuses on developing precision therapeutics for genetic diseases. Headquartered in South San Francisco, California, the company relies on a team of scientific experts and entrepreneurs.
Addition Therapeutics is a biotechnology research company based in South San Francisco, California. The firm is on a mission to fulfill the promise of genomic medicine for chronic and rare diseases, having emerged from stealth with significant funding.
GeneTether, Inc., also known as Rize Oncology, is a biotechnology company headquartered in San Lorenzo, California, focused on developing proprietary gene-editing technologies and targeted oncology therapeutics.
Averna Therapeutics is a biotechnology company developing genomic medicines utilizing RNA and lipid nanoparticle technologies. The company focuses on safe and efficient gene insertion and the treatment of rare genetic diseases through research and development teams located in Boston and Israel.
Get SonoThera's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on SonoThera in Xcout Intel
- 12 named people with titles, LinkedIn and board committees
- 3 funding rounds with the investors in each, and who they co-invest with
- Weekly hiring history and the mix of roles behind it
- The full competitor set, tracking, exports and API access